开发用于监测前列腺癌男性放射治疗照护的质量指标:改良德尔菲法
本研究采用RAND改良德尔菲法,通过文献综述和12名专家组成的小组进行三轮投票,从144项候选质量指标中筛选出17项核心质量指标,其中16项(94.1%)评估照护过程,1项评估健康结局,将用于澳大利亚和新西兰前列腺癌结局登记处报告放射治疗照护质量。
要点
- 研究采用RAND改良德尔菲法,由12名专家经三轮投票从144项候选指标中选出17项核心质量指标。
- 17项质量指标中16项(94.1%)评估照护过程,其余1项评估健康结局。
- 该核心指标集将用于澳大利亚和新西兰前列腺癌结局登记处报告放射治疗照护质量。
核心结论
- 本研究开发了一套包含17项质量指标的核心指标集,将用于澳大利亚和新西兰前列腺癌结局登记处报告,以监测前列腺癌患者接受的放射治疗照护质量。
研究设计与样本
- 采用RAND改良德尔菲法,分两阶段:先通过文献综述识别候选质量指标,再由12名专家组成的小组进行三轮投票(两轮在线问卷和一轮面对面会议)筛选指标。
- 每轮投票后依据RAND标准识别评分差异并确定共识水平。
主要发现
- 文献综述共识别出144项候选质量指标,涵盖从治疗前到治疗后及生存期照护的测量。
- 经三轮投票后,专家小组批准了17项质量指标,其中16项(94.1%)评估照护过程,其余1项评估健康结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Quality indicators (QIs) have been developed for many aspects of prostate cancer care, but are under-developed with regard to radiotherapy treatment. We aimed to develop a valid, relevant and feasible set of core QIs to measure quality of radiotherapy care in men with prostate cancer. MATERIALS AND METHODS: We used a RAND-modified Delphi process to select QIs that were regarded as both important and feasible measures of quality radiotherapy care. This involved two phases: (1) a literature review to identify a list of proposed QIs; and (2) a QI selection process by an expert panel (n = 12) conducted in a series of three rounds: two online questionnaires' and one face-to-face meeting. The RAND criterion identified variation in ratings and determined the level of agreement after each round of voting. RESULTS: A total of 144 candidate QIs, which included measures from pre-treatment to post-treatment and survivorship care were identified. After three rounds of voting, the panel approved a comprehensive set of 17 QIs, with most assessing a process of care (n = 16, 94.1%) and the remaining assessing a health outcome. CONCLUSION: This study developed a core set of 17 QIs which will be used to report from the Prostate Cancer Outcomes Registry-Australia & New Zealand, to monitor the quality of radiotherapy care prostate cancer patients receive.
引用
- Tsiamis E, Millar J, Baxi S, et al. Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method. Radiother Oncol. 2018. PMID: 29753551. doi:10.1016/j.radonc.2018.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。